Abcellera Accounts Payable vs Current Deferred Revenue Analysis
ABCL Stock | USD 3.64 0.14 3.70% |
Abcellera BiologicsInc financial indicator trend analysis is way more than just evaluating Abcellera BiologicsInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abcellera BiologicsInc is a good investment. Please check the relationship between Abcellera BiologicsInc Accounts Payable and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
Accounts Payable vs Current Deferred Revenue
Accounts Payable vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abcellera BiologicsInc Accounts Payable account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong relationship.
The correlation between Abcellera BiologicsInc's Accounts Payable and Current Deferred Revenue is 0.77. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Abcellera BiologicsInc, assuming nothing else is changed. The correlation between historical values of Abcellera BiologicsInc's Accounts Payable and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Abcellera BiologicsInc are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Accounts Payable i.e., Abcellera BiologicsInc's Accounts Payable and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.77 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Abcellera BiologicsInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Abcellera BiologicsInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Abcellera BiologicsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abcellera BiologicsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.At this time, Abcellera BiologicsInc's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 1.68 this year, although the value of Tax Provision is projected to rise to (26.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.8M | 59.7M | 30.9M | 20.4M | Interest Income | 3.3M | 16.1M | 42.2M | 44.4M |
Abcellera BiologicsInc fundamental ratios Correlations
Click cells to compare fundamentals
Abcellera BiologicsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Abcellera BiologicsInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 23.5M | 1.0B | 1.3B | 1.5B | 1.5B | 989.6M | |
Short Long Term Debt Total | 6.9M | 6.1M | 36.4M | 82.3M | 77.4M | 39.0M | |
Other Current Liab | 129.3K | 76.7M | 77.5M | 58.0M | 61.3M | 50.2M | |
Total Current Liabilities | 7.9M | 103.5M | 120.7M | 118.3M | 119.0M | 87.2M | |
Total Stockholder Equity | 10.3M | 830.5M | 1.0B | 1.2B | 1.2B | 781.7M | |
Other Liab | 1.3M | 65.6M | 134.0M | 112.6M | 129.5M | 69.6M | |
Net Tangible Assets | 2.7M | 683.9M | 829.5M | 1.1B | 1.2B | 1.3B | |
Property Plant And Equipment Net | 8.5M | 17.9M | 111.6M | 217.3M | 287.7M | 302.1M | |
Current Deferred Revenue | 3.2M | 6.6M | 7.5M | 21.6M | 26.1M | 27.4M | |
Net Debt | (661.9K) | (588.0M) | (439.7M) | (304.3M) | (55.9M) | (58.7M) | |
Retained Earnings | (4.7M) | 114.2M | 267.7M | 426.2M | 279.8M | 198.1M | |
Accounts Payable | 1.6M | 20.0M | 32.0M | 33.2M | 25.5M | 20.9M | |
Cash | 7.6M | 594.1M | 476.1M | 386.5M | 133.3M | 126.7M | |
Non Current Assets Total | 10.8M | 192.2M | 388.8M | 515.4M | 616.1M | 317.1M | |
Cash And Short Term Investments | 7.6M | 594.1M | 723.0M | 886.5M | 760.6M | 546.7M | |
Net Receivables | 4.4M | 213.2M | 160.6M | 38.6M | 64.4M | 89.0M | |
Common Stock Total Equity | 5.1M | 710.4M | 722.4M | 734.4M | 844.5M | 479.0M | |
Common Stock Shares Outstanding | 154.1M | 269.5M | 318.3M | 314.8M | 289.2M | 290.3M | |
Liabilities And Stockholders Equity | 23.5M | 1.0B | 1.3B | 1.5B | 1.5B | 989.6M | |
Non Current Liabilities Total | 5.3M | 71.5M | 172.2M | 189.3M | 216.8M | 120.7M | |
Capital Lease Obligations | 3.1M | 3.7M | 36.4M | 82.3M | 77.4M | 81.2M | |
Other Current Assets | 1.8M | 6.0M | 21.2M | 75.4M | 20.9M | 23.1M | |
Other Stockholder Equity | 2.3M | 5.9M | 35.4M | 74.1M | 121.1M | 127.1M | |
Total Liab | 13.2M | 175.0M | 292.8M | 307.6M | 335.8M | 208.0M | |
Net Invested Capital | 6.5M | 832.9M | 1.0B | 1.2B | 1.2B | 780.7M | |
Property Plant And Equipment Gross | 8.5M | 17.9M | 121.4M | 235.7M | 318.3M | 334.2M | |
Total Current Assets | 12.6M | 813.3M | 929.8M | 1.0B | 872.0M | 672.5M | |
Capital Stock | 12.7M | 710.4M | 722.4M | 734.4M | 753.2M | 540.0M | |
Net Working Capital | 4.7M | 709.8M | 809.1M | 907.2M | 753.0M | 585.3M | |
Short Term Debt | 2.9M | 190K | 3.7M | 5.6M | 6.2M | 3.9M | |
Common Stock | 5.1M | 710.4M | 722.4M | 734.4M | 753.2M | 537.3M | |
Property Plant Equipment | 8.5M | 17.9M | 111.6M | 217.3M | 249.8M | 262.3M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Abcellera BiologicsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.